Pharma Capital
EPIC: SPH
Market: LSE
52-week High/Low: 36.35p / 26.00p
Sector: Pharma & Biotech
Market Cap: 133.50M

Sinclair Pharma plc is an international company operating in the fast growth, high gross margin, global aesthetics market. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies, which are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural looking and minimally-invasive treatments. The Company is planning entry to multiple new geographic markets and line extension launches over the next few years. Sinclair has an established sales and marketing presence in the leading EU markets and Brazil, and a network of international distributors. 

Sinclair Pharma

www.sinclairpharma.com

Interactive graph

col 3
col 4
col 5
col 6

Sinclair Pharma Timeline

View All

Market Reports Including SPH

VIEW ALL

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.